Innophos Holdings (IPHS) Cash Flow Statement

Click line-items for a historical chart and %

Net Income	38.59M
Depreciation and amortization	28.61M
Amortization of deferred financing charges	505K
Deferred income tax provision	363K
Deferred profit sharing
Share-based compensation	2.33M
Decrease in restricted cash
Increase in accounts receivable	-107K
Increase in inventories	33.09M
Decrease (increase) in other current assets	2.1M
Increase in accounts payable	-2.55M
Decrease in other current liabilities	-16.15M
Changes in other long-term assets and liabilities	-4.99M
Net cash provided from operating activities	81.8M
Capital expenditures	-25.68M
Net cash used for investing activities	-25.68M
Proceeds from exercise of stock options	9K
Long-term debt repayments	-49M
Excess tax benefits from exercise of stock options	-346K
Common stock repurchases	-331K
Dividends paid	-27.89M
Net cash used for financing activities	-41.56M
Net change in cash	14.89M
Cash and cash equivalents at beginning of period	17.91M
Cash and cash equivalents at end of period	32.8M

Entities mentioned with IPHS

View All Entities